JUSTIN PARROTT: Open Payments
NPI 1053677179 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,296 in 112 payments from 18 companies in 2025. Trend: 2023 $2,405 · 2024 $2,231 · 2025 $2,296
Food & beverage: $2,296
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 21 | $566 |
| ABBVIE INC. | 23 | $320 |
| Vanda Pharmaceuticals Inc. | 13 | $299 |
| Axsome Therapeutics, Inc. | 13 | $264 |
| Alkermes, Inc. | 7 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $134 |
| Corium, LLC | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $105 |
| Lundbeck LLC | 4 | $74 |
| Tris Pharma Inc | 4 | $67 |
Products named: INGREZZA, VRAYLAR, FANAPT, Auvelity, ARISTADA, CAPLYTA, REXULTI, Azstarys.
Industry payments across AL — which companies pay providers there.
